ABUS

Arbutus Biopharma Corp

ABUS
NasdaqSmall CapHealthcare

13F Pro Quality Score

64.1/100

Rank #570 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$1.01M

Net Income

Q2 2026
EDGAR

$-5.14M

EPS (Diluted)

Q2 2026
EDGAR

$-0.03

ROIC

Q2 2026
EDGAR

-9.2%

Debt/Equity

Q2 2026
EDGAR

0.00

Top Institutional Holders

as of Q2 2026
$677.22M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…